Larvol Delta - Completion-of-Enrolment-and-Treatment-in-the-Phase-1-Study-of-MTX110-in-the-Treatment-of-Children-with-Newly-Diagnosed-Diffuse-Midline-Gliomas-DMGs

panobinostat (MTX110) - Biodexa Pharma

https://www.globenewswire.com/news-release/2023/07/10/2701723/0/en/Completion-of-Enrolment-and-Treatment-in-the-Phase-1-Study-of-MTX110-in-the-Treatment-of-Children-with-Newly-Diagnosed-Diffuse-Midline-Gliomas-DMGs.html

Jul 10, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next